SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001654954-24-001542
Filing Date
2024-02-09
Accepted
2024-02-09 17:00:57
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B4 tenx_424b4.htm 424B4 1728362
2 tenx_s1img4.jpg GRAPHIC 10379
3 tenx_s1img32.jpg GRAPHIC 702
4 tenx_s1img31.jpg GRAPHIC 702
5 tenx_s1img30.jpg GRAPHIC 702
6 tenx_s1img3.jpg GRAPHIC 6869
7 tenx_s1img28.jpg GRAPHIC 702
8 tenx_s1img27.jpg GRAPHIC 688
9 tenx_s1img25.jpg GRAPHIC 688
10 tenx_s1img23.jpg GRAPHIC 688
11 tenx_s1img21.jpg GRAPHIC 688
12 tenx_s1img20.jpg GRAPHIC 688
13 tenx_s1img19.jpg GRAPHIC 688
14 tenx_s1img18.jpg GRAPHIC 688
  Complete submission text file 0001654954-24-001542.txt   1765593
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-275856 | Film No.: 24615929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)